Researchers Develop New Drug-Like Molecule to Treat Fragile X Syndrome, the Most Common Genetic Cause of Autism
Links shared publicly online about this topic.
- 0total visits
Researchers Develop New Drug-Like Molecule to Treat Fragile X Syndrome, the Most Common Genetic Cause of Autism
Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism.
View full resource at newswise.com
Tags: Genetic, Fragile X, Autism, Disease and Condition, Healthy Living, News
Most Recently Shared on September 15, 2011 at 5:04 pm By:
#health news: Researchers Develop New Drug-Like Molecule to Treat Fragile X Syndrome, the Most Common Genetic Ca... http://t.co/wrdXoGjr
Advertisement
